Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients (Q58621125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

acute myeloid leukemia

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

G Pittari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

G Fregni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

L Roguet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A Garcia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A-L Vataire

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

S Wittnebel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

S Amsellem

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

S Chouaib

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

J-H Bourhis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

5 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

862-871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.265

9 February 2020

exact match

0 references

cites work

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

What is a natural killer cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Regulation of immune responses through inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Activation, coactivation, and costimulation of resting human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Immune inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

MHC class I molecules and KIRs in human history, health and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Delivering the kiss of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

CD107a as a functional marker for the identification of natural killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Interleukin (IL)-15Rα–deficient Natural Killer Cells Survive in Normal but Not IL-15Rα–deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

NK cells: a lesson from mismatched hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

7 January 2021

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

7 January 2021

In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

7 January 2021

Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.265

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19802033%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference